Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

234.13

+12.17 (5.48%)

At close: Dec 5, 2025, 4:00 PM EST

235.00

+0.87 (0.37%)

After-hours: Dec 5, 2025, 7:58 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Genetic Medicines	290.52M	Log In
Genetic Medicines Growth	473.02%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	290.52M	Log In
United States Growth	473.02%	Log In